Haemonetics Corporation, a global leader in blood management technologies, has acquired Vivasure Medical Limited for an upfront cash payment of EUR 100 million and up to an additional EUR 85 million based on sales growth and milestone achievements. The deal closed on January 12, 2026.
| Acquirer | Haemonetics Corporation (US) |
|---|---|
| Target | Vivasure Medical Limited (IE) |
| Value | EUR 185m ($214m) upfront + EUR 85m contingent consideration |
| Type | Acquisition |
| Date closed | January 12, 2026 |
| Advisors buy-side | Not disclosed |
| Advisors sell-side | Not disclosed |
Deal Mechanics:
The transaction comprises an initial cash payment of EUR 100 million and up to an additional EUR 85 million based on Vivasure achieving sales growth targets and specific performance milestones. The deal aims to enhance Haemonetics' portfolio with new technologies that differentiate their products in the large-bore closure market.
Strategic Rationale:
The acquisition allows Haemonetics to strengthen its product offerings by integrating Vivasure's innovative technology, which provides clinically differentiating solutions for blood management. This move is expected to expand Haemonetics' global footprint and position it competitively within the healthcare sector.
Financial Context:
Vivasure Medical has been recognized for its cutting-edge medical devices that streamline post-procedure patient care, offering a significant opportunity for Haemonetics to drive revenue growth through enhanced product offerings. The additional EUR 85 million contingent upon Vivasure's performance underscores the strategic importance of this acquisition in bolstering Haemonetics' market position.
Advisors:
The transaction was facilitated without disclosed buy-side and sell-side advisors or legal counsel, indicating a streamlined process focused on the deal's financial aspects rather than traditional advisory roles.
Outlook:
Haemonetics aims to leverage Vivasure’s technology to drive market penetration in high-growth regions. The company anticipates significant synergies from integrating Vivasure's products into its existing portfolio, positioning itself for long-term growth and leadership within the healthcare industry.